News
2h
Health and Me on MSNNew WHO Guidelines Reveal The Blueprint To Manage Dengue, Chikungunya, Yellow Fever And ZikaWHO has released its first unified clinical guidelines for managing dengue, Zika, chikungunya, and yellow fever, aiming to ...
6h
Philstar Life on MSNDon’t let rainy days get you downThe rainy season can often bring back lonely memories of the past or shift your mood from happiness to sadness. Yetfor many, ...
13h
DPA International on MSNChikungunya: The virus you might not know you need to worry aboutMost European travellers heading to sub-tropical regions know to make sure they're up to date on their vaccinations. While ...
Two more deaths were reported from dengue in 24 hours till this morning (14 July), raising the death toll from the mosquito-borne disease to 58 this year, according to the Directorate General of ...
1don MSN
WHO has released its first-ever clinical guidelines to standardise treatment of mosquito-borne diseases like dengue, chikungunya, Zika, and yellow fever - the guidelines address both severe and mild ...
West Nile virus is spreading in Fulton County, Georgia, with positive tests found in mosquito traps. The virus transmits through infected mosquitoes, posing a higher risk to those over 50 and with ...
838 new cases were recorded in the past week alone, pushing the total for the year to 14,370, a surge of more than 153 percent compared to the same period last year.
1d
Health and Me on MSNWHO Releases First-Ever Clinical Guidelines For Arboviral Diseases Amid Rising Global ThreatThe WHO has released its first-ever clinical guidelines for managing arboviral diseases like dengue, chikungunya, Zika, and ...
Health officials are warning travellers of a mosquito-borne virus that can cause debilitating joint pain, after cases emerged in areas of France.
The one-shot vaccine, developed by Panacea Biotec and branded as DengiAll, is being tested through a multi-centre, ...
1don MSN
Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...
The phase III clinical trial enrolment for India's first one-shot dengue vaccine, DengiAll, developed by Panacea Biotec, is set to complete with 10,500 participants across 20 centers. This trial aims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results